Literature DB >> 24199935

Natural history and retinal structure in patients with Usher syndrome type 1 owing to MYO7A mutation.

Eva Lenassi1, Zubin Saihan2, Valentina Cipriani3, Polona Le Quesne Stabej4, Anthony T Moore3, Linda M Luxon5, Maria Bitner-Glindzicz4, Andrew R Webster6.   

Abstract

PURPOSE: To evaluate the phenotypic variability and natural history of ocular disease in a cohort of 28 individuals with MYO7A-related disease. Mutations in the MYO7A gene are the most common cause of Usher syndrome type 1, characterized by profound congenital deafness, vestibular arreflexia, and progressive retinal degeneration.
DESIGN: Retrospective case series. PARTICIPANTS: Twenty-eight patients from 26 families (age range, 3-65 years; median, 32) with 2 likely disease-causing variants in MYO7A.
METHODS: Clinical investigations included fundus photography, optical coherence tomography, fundus autofluorescence (FAF) imaging, and audiologic and vestibular assessments. Longitudinal visual acuity and FAF data (over a 3-year period) were available for 20 and 10 study subjects, respectively. MAIN OUTCOME MEASURES: Clinical, structural, and functional characteristics.
RESULTS: All patients with MYO7A mutations presented with features consistent with Usher type 1. The median visual acuity for the cohort was 0.39 logarithm of the minimum angle of resolution (logMAR; range, 0.0-2.7) and visual acuity in logMAR correlated with age (Spearman's rank correlation coefficient, r = 0.71; P<0.0001). Survival analysis revealed that acuity ≤ 0.22 logMAR was maintained in 50% of studied subjects until age 33.9; legal blindness based on loss of acuity (≥ 1.00 logMAR) or loss of field (≤ 20°) was reached at a median age of 40.6 years. Three distinct patterns were observed on FAF imaging: 13 of 22 patients tested had relatively preserved foveal autofluorescence surrounded by a ring of high density, 4 of 22 had increased signal in the fovea with no obvious hyperautofluorescent ring, and 5 of 22 had widespread hypoautofluorescence corresponding to retinal pigment epithelial atrophy. Despite a number of cases presenting with a milder phenotype, there seemed to be no obvious genotype-phenotype correlation.
CONCLUSIONS: MYO7A-related ocular disease is variable. Central vision typically remains preserved at least until the third decade of life, with 50% of affected individuals reaching legal blindness by 40 years of age. Distinct phenotypic subsets were identified on FAF imaging. A specific allele, previously reported in nonsyndromic deafness, may be associated with a mild retinopathy.
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24199935     DOI: 10.1016/j.ophtha.2013.09.017

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

1.  Variability and Errors of Manually Digitized Goldmann Visual Fields.

Authors:  Michael P Barry; Ava K Bittner; Liancheng Yang; Rebecca Marcus; Mian Haris Iftikhar; Gislin Dagnelie
Journal:  Optom Vis Sci       Date:  2016-07       Impact factor: 1.973

2.  Full-field electroretinography, visual acuity and visual fields in Usher syndrome: a multicentre European study.

Authors:  Katarina Stingl; Anne Kurtenbach; Gesa Hahn; Christoph Kernstock; Stephanie Hipp; Ditta Zobor; Susanne Kohl; Crystel Bonnet; Saddek Mohand-Saïd; Isabelle Audo; Ana Fakin; Marko Hawlina; Francesco Testa; Francesca Simonelli; Christine Petit; Jose-Alain Sahel; Eberhart Zrenner
Journal:  Doc Ophthalmol       Date:  2019-07-02       Impact factor: 2.379

3.  Detecting novel genetic mutations in Chinese Usher syndrome families using next-generation sequencing technology.

Authors:  Ling-Hui Qu; Xin Jin; Hai-Wei Xu; Shi-Ying Li; Zheng-Qin Yin
Journal:  Mol Genet Genomics       Date:  2014-09-25       Impact factor: 3.291

4.  Multimodal Imaging of Central Retinal Disease Progression in a 2-Year Mean Follow-up of Retinitis Pigmentosa.

Authors:  Tharikarn Sujirakul; Michael K Lin; Jimmy Duong; Ying Wei; Sara Lopez-Pintado; Stephen H Tsang
Journal:  Am J Ophthalmol       Date:  2015-07-09       Impact factor: 5.258

5.  CRISPR/Cas9 editing of the MYO7A gene in rhesus macaque embryos to generate a primate model of Usher syndrome type 1B.

Authors:  Junghyun Ryu; John P Statz; William Chan; Fernanda C Burch; John V Brigande; Beth Kempton; Edward V Porsov; Lauren Renner; Trevor McGill; Benjamin J Burwitz; Carol B Hanna; Martha Neuringer; Jon D Hennebold
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

Review 6.  Review of Genotype-Phenotype Correlations in Usher Syndrome.

Authors:  Eric Nisenbaum; Torin P Thielhelm; Aida Nourbakhsh; Denise Yan; Susan H Blanton; Yilai Shu; Karl R Koehler; Aziz El-Amraoui; Zhengyi Chen; Byron L Lam; Xuezhong Liu
Journal:  Ear Hear       Date:  2022 Jan/Feb       Impact factor: 3.562

7.  Retrospective Analysis of Structural Disease Progression in Retinitis Pigmentosa Utilizing Multimodal Imaging.

Authors:  Thiago Cabral; Jesse D Sengillo; Jimmy K Duong; Sally Justus; Katherine Boudreault; Kaspar Schuerch; Rubens Belfort; Vinit B Mahajan; Janet R Sparrow; Stephen H Tsang
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

Review 8.  Correction of Monogenic and Common Retinal Disorders with Gene Therapy.

Authors:  Jesse D Sengillo; Sally Justus; Thiago Cabral; Stephen H Tsang
Journal:  Genes (Basel)       Date:  2017-01-27       Impact factor: 4.096

9.  Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps.

Authors:  Jacque L Duncan; Eric A Pierce; Amy M Laster; Stephen P Daiger; David G Birch; John D Ash; Alessandro Iannaccone; John G Flannery; José A Sahel; Donald J Zack; Marco A Zarbin
Journal:  Transl Vis Sci Technol       Date:  2018-07-18       Impact factor: 3.283

Review 10.  Usher Syndrome: Genetics and Molecular Links of Hearing Loss and Directions for Therapy.

Authors:  Meg Whatley; Abbie Francis; Zi Ying Ng; Xin Ee Khoh; Marcus D Atlas; Rodney J Dilley; Elaine Y M Wong
Journal:  Front Genet       Date:  2020-10-22       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.